Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma.
Gray ES, Rizos H, Reid AL, Boyd SC, Pereira MR, Lo J, Tembe V, Freeman J, Lee JH, Scolyer RA, Siew K, Lomma C, Cooper A, Khattak MA, Meniawy TM, Long GV, Carlino MS, Millward M, Ziman M.
Gray ES, et al.
Oncotarget. 2015 Dec 8;6(39):42008-18. doi: 10.18632/oncotarget.5788.
Oncotarget. 2015.
PMID: 26524482
Free PMC article.